The week in industry: US FDA awards 12 grants to fund rare disease treatment programs
This week: US$3 million payment for nomination of new GPCR target, orphan drug designation granted for soft tissue sarcoma treatment and erythropoietic protoporphyria drug approved for marketing in the US.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>